| Medical and Health Sciences | Lifetime | 616 | US 326 | 99.97 |
| Biological Sciences | Lifetime | 923 | US 501 | 99.89 |
| Medical Physiology | Lifetime | 6 | US 4 | 99.99 |
| Neuroscience of Neurology | Lifetime | 127 | US 54 | 98.98 |
| Clinical Neurology | Lifetime | 301 | US 139 | 98.80 |
| Psychiatry and Mental health | Lifetime | 398 | US 208 | 98.71 |
| Cellular and Molecular Neuroscience | Lifetime | 398 | US 217 | 98.55 |
| Clinical Pharmacology | Lifetime | 962 | US 412 | 95.42 |
| Biophysics | Lifetime | 288 | US 128 | 92.81 |
| Medical Physiology | 2021-2025 | 16 | US 10 | 99.72 |
| Neuroscience of Neurology | 2021-2025 | 126 | US 41 | 93.24 |
| Psychiatry and Mental health | 2021-2025 | 540 | US 209 | 83.49 |
| Alzheimer's disease research and treatments | Lifetime | 5 | US 4 | 99.98 |
| Cholinesterase and Neurodegenerative Diseases | Lifetime | 6 | US 5 | 99.87 |
| Neuroinflammation and Neurodegeneration Mechanisms | Lifetime | 16 | US 11 | 99.90 |
| Nuclear Receptors and Signaling | Lifetime | 8 | US 7 | 99.82 |
| Computational Drug Discovery Methods | Lifetime | 60 | US 34 | 99.44 |
| Dementia and Cognitive Impairment Research | Lifetime | 54 | US 27 | 99.79 |
| Neuroscience and Neuropharmacology Research | Lifetime | 134 | US 76 | 99.76 |
| S100 Proteins and Annexins | Lifetime | 30 | US 14 | 99.33 |
| Neurological Disease Mechanisms and Treatments | Lifetime | 35 | US 17 | 99.70 |
| Amyloidosis: Diagnosis, Treatment, Outcomes | Lifetime | 48 | US 30 | 99.12 |
| Parkinson's Disease Mechanisms and Treatments | Lifetime | 196 | US 73 | 99.32 |
| Prion Diseases and Protein Misfolding | Lifetime | 48 | US 23 | 98.95 |
| Cell Image Analysis Techniques | Lifetime | 199 | US 108 | 96.85 |
| Memory and Neural Mechanisms | Lifetime | 502 | US 277 | 97.43 |
| Bioinformatics and Genomic Networks | Lifetime | 646 | US 284 | 95.78 |
| Cellular transport and secretion | Lifetime | 705 | US 316 | 96.66 |
| Genetic Neurodegenerative Diseases | Lifetime | 771 | US 301 | 96.11 |
| Neuroprotection in Stroke and Neurodegeneration | Lifetime | 576 | US 177 | 94.83 |
| Advanced Fluorescence Microscopy Techniques | Lifetime | 648 | US 272 | 95.30 |
| Ginkgo biloba and Cashew Applications | Lifetime | 137 | US 45 | 94.42 |
| Neurological diseases and metabolism | Lifetime | 880 | US 299 | 91.03 |
| Clusterin in disease pathology | Lifetime | 165 | US 44 | 82.53 |
| GDF15 and Related Biomarkers | Lifetime | 982 | US 297 | 72.86 |
| Alzheimer's disease research and treatments | 2021-2025 | 25 | US 15 | 99.73 |
| Neuroinflammation and Neurodegeneration Mechanisms | 2021-2025 | 32 | US 14 | 99.02 |
| Prion Diseases and Protein Misfolding | 2021-2025 | 18 | US 3 | 95.00 |
| Neuroscience and Neuropharmacology Research | 2021-2025 | 289 | US 108 | 94.85 |
| Dementia and Cognitive Impairment Research | 2021-2025 | 481 | US 204 | 95.97 |
| Nuclear Receptors and Signaling | 2021-2025 | 35 | US 11 | 90.71 |
| Cholinesterase and Neurodegenerative Diseases | 2021-2025 | 374 | US 32 | 83.76 |
| RNA regulation and disease | 2021-2025 | 731 | US 195 | 72.89 |
| Neurological Disease Mechanisms and Treatments | 2021-2025 | 793 | US 153 | 74.89 |
| S100 Proteins and Annexins | 2021-2025 | 904 | US 207 | 60.85 |
| GDF15 and Related Biomarkers | 2021-2025 | 924 | US 224 | 42.07 |
